Tobacco carcinogens, their biomarkers and tobacco-induced cancer

Nature Reviews Cancer

Volumn 3, Issue 10, 2003, Pages 733-744

  Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4 BIPHENYLAMINE; AROMATIC AMINE; BENZO[A]PYRENE; BIOLOGICAL MARKER; CARCINOGEN; CIGARETTE SMOKE; NITROSAMINE; NITROSONORNICOTINE; POLYCYCLIC AROMATIC HYDROCARBON; TOBACCO SMOKE; UNCLASSIFIED DRUG; TUMOR MARKER;

ADDICTION; BLADDER CANCER; CANCER RISK; CARCINOGENESIS; CAUSE OF DEATH; CHEMICAL STRUCTURE; DNA ADDUCT; DNA DAMAGE; DOSE RESPONSE; ENZYME ACTIVATION; ESOPHAGUS CANCER; GENE MUTATION; HUMAN; HYPOPHARYNX CANCER; KIDNEY CANCER; LARYNX CANCER; LIVER CANCER; LUNG CANCER; MOUTH CANCER; MYELOID LEUKEMIA; NONHUMAN; NUCLEOTIDE SEQUENCE; OROPHARYNX CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN ADDUCT; REVIEW; SMOKING; STOMACH CANCER; TOBACCO; TOBACCO DEPENDENCE; URETER CANCER; URINE LEVEL; CHEMICALLY INDUCED DISORDER; METABOLISM; NEOPLASM;

CARCINOGENS; HUMANS; NEOPLASMS; TOBACCO; TUMOR MARKERS, BIOLOGICAL;

EID: 0142228320     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1190     Document Type: Review

References (145)

1. Mackay, J. & Eriksen, M. The Tobacco Atlas (World Health Organization, Geneva, 2002).
2. World Health Organization. The World Health Report 2002. Reducing Risks, Promoting Healthy Life (World Health Organization, Geneva, 2002).
3. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Vol. 83 (IARC, Lyon, in the press).
4. International Agency for Research on Cancer. Tobacco habits other than smoking: betel quid and Areca nut chewing and some related nitrosamines. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans Vol. 37, 37-202 (IARC, Lyon, 1985).
5. International Agency for Research on Cancer. Tobacco Smoking. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans Vol. 38, 37-375 (IARC, Lyon, 1986).
6. Hoffmann, D., Hoffmann, I. & El Bayoumy, K. The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem. Res. Toxicol. 14, 767-790 (2001).
7. Hoffmann, D., Adams, J. D., Lisk, D., Fisenne, I. & Brunnemann, K. D. Toxic and carcinogenic agents in dry and moist snuff. J. Natl Cancer Inst. 79, 281-286 (1987).
8. Hoffmann, D. et al. Five leading US commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines. J. Natl Cancer Inst. 87, 1862-1869 (1995).
9. Hecht, S. S. in Environmental and Occupational Medicine (ed. Rom, W. N.) 1479-1499 (Lippincott-Raven, New York, 1998).
10. Swauger, J. E., Steichen, T. J., Murphy, P. A. & Kinsler, S. An analysis of the mainstream smoke chemistry of samples of the US cigarette market acquired between 1995 and 2000. Regul. Toxicol. Pharmacol. 35, 142-156 (2002).
11. British Columbia Ministry of Health Planning. What is in Cigarettes? [online], (cited 4 Sept 2003), 〈http://www healthplanning.gov.bc.ca/ttdr/index.html〉.
12. Phillips, D. H. Fifty years of benzo[a]pyrene. Nature 303, 468-472 (1983).
13. Cooper, R. L., Lindsey, A. J., & Waller, R. E. The presence of 3,4-benzopyrene in cigarette smoke. Chem. Ind. 46, 1418 (1954)
14. Denissenko, M. F., Pao, A., Tang, M. & Pfeifer, G. P. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hot spots in p53. Science 274, 430-432 (1996). Proposes a role for benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts as causes of mutations found in the TP53 gene in lung cancer.
15. Pfeifer, G. P. et al. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21, 7435-7451 (2002).
16. Ross, J. A. et al. Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels. Cancer Res. 55, 1039-1044 (1995).
17. Hoffmann, D., Schmeltz, I., Hecht, S. S. & Wynder, E. L. in Polycyclic Hydrocarbons and Cancer (eds Gelboin, H. & Ts'o, P. O. P.) 85-117 (Academic, New York, 1978).
18. Hecht, S. S. & Hoffmann, D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 9, 875-884 (1988).
19. Spiegelhalder, B. & Bartsch, H. Tobacco-specific nitroSamines. Eur. J. Cancer Prev. 5, 33-38 (1996).
20. Hoffmann, D., Brunnemann, K. D., Prokopczyk, B. & Djordjevic, M. V. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J. Toxicol. Environ. Health 41, 1-52 (1994).
21. Vainio, H. & Weiderpeas, E. Smokeless tobacco: harm reduction or nicotine overload? Eur. J. Cancer Prev. 12, 89-92 (2003).
22. Hecht, S. S. Tobacco smoke carcinogens and lung cancer. J. Natl Cancer Inst. 91, 1194-1210 (1999).
23. International Agency for Research on Cancer. Polynuclear aromatic compounds, part 1: chemical, environmental, and experimental data. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans Vol. 32, 33-91 (IARC, Lyon, 1983).
24. Deutsch-Wenzel, R., Brune, H. & Grimmer, G. Experimental studies in rat lungs on the carcinogenicity and dose-response relationships of eight frequently occurring environmental polycyclic aromatic hydrocarbons. J. Natl Cancer Inst. 71, 539-544 (1983).
25. Boysen, G. & Hecht, S. S. Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods. Mutation Res. 543, 17-30 (2003).
26. Phillips, D. H. Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 23, 1979-2004 (2002). Provides a comprehensive review of DNA and protein adducts of cigarette-smoke carcinogens in human tissues.
27. Hecht, S. S. Biochemistry, biology and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol. 11, 559-603 (1998).
28. 6-methylguanine adducts in rats,
29. Schlöbe, D., Hölze, D., Richter, E. & Tricker, A. R. Determination of tobacco-specific nitrosamine hemoglobin and lung DNA adducts. Proc. Am. Assoc. Cancer Res. 43, 346 (2002).
30. Hecht, S. S. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 23, 907-922 (2002). Provides a comprehensive review of urinary metabolites and related compounds as tobacco-carcinogen biomarkers.
31. Shapiro, J. A., Jacobs, E. J. & Thun, M. J. Cigar smoking in men and risk of death from tobacco-related cancers. J. Natl Cancer Inst. 92, 333-337 (2000).
32. Boffetta, P. et al. Cigar and pipe smoking and lung cancer risk: a multicenter study from Europe. J. Natl Cancer Inst. 91, 697-701 (1999).
33. Travis, W. D., Travis, L. B. & Devesa, S. S. Lung cancer. Cancer 15, 191-202 (1995).
34. Preussmann, R. & Stewart, B. W. in Chemical Carcinogens 2nd edn (ed. Searle, C. E.) American Chemical Society Monograph 182 Vol. 2, 643-828 (ACS, Washington DC, 1984).
35. International Agency for Research on Cancer. Wood dust and formaldehyde. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans Vol. 62, 217-362 (IARC, Lyon, 1995).
36. International Agency for Research on Cancer. Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide (part two). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans Vol. 71, 319-335 (IARC, Lyon, 1999).
37. Hoffmann, D. & Hecht, S. S. in Handbook of experimental Pharmacology (eds Cooper, C. S. & Grover, P. L.) 63-102 (Springer-Verlag, Heidelberg, 1990).
38. Hecht, S. S. et al. Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res 46, 4162-4166 (1986). Shows that a mixture of NNN and NNK induces oral tumours in rats and that oral tumours can also be induced by snuff.
39. Lijinsky, W. Chemistry and Biology of N-Nitroso Compounds (Cambridge Univ. Press, Cambridge, England, 1992).
40. Hecht, S. S. & Hoffmann, D. The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv. 8, 273-294 (1989).
41. International Agency for Research on Cancer. Dry cleaning, some chlorinated solvents and other industrial chemicals. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Vol. 63, 393-407 (IARC, Lyon, France, 1995).
42. Rivenson, A., Hoffmann, D., Prokopczyk, B., Amin, S. & Hecht, S. S. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res. 48, 6912-6917 (1988). Shows that NNK induces tumours of the lung and pancreas when administered in drinking water to rats.
43. Prokopczyk, B. et al, Identification of tobacco-derived compounds in human pancreatic juice. Chem. Res. Toxicol. 15, 677-685 (2002).
44. Prokopczyk, B., Trushin, N., Leszczynska, J., Waggoner, S. E. & El Bayoumy, K. Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via α-hydroxylation and carbonyl reduction pathways. Carcinogenesis 22, 107-114 (2001).
45. Melikian, A. A. et al. Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry. Cancer Lett. 146, 127-134 (1999).
46. International Agency for Research on Cancer. Human papillomaviruses. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans Vol. 64., 35-378 (IARC, Lyon, 1995).
47. International Agency for Research on Cancer. Some aromatic amines, hydrazine and related substances, N-nitroso compounds and miscellaneous alkylating agents. IARC Monographs on the Carcinogenic Risk of Chemicals to Man Vol. 4, 97-111 (IARC, Lyon, FR, 1973).
48. Skipper, P. L. & Tannenbaum, S. P. Protein adducts in the molecular dosimetry of chemical carcinogens Carcinogenesis 11, 507-518 (1990).
49. Skipper, PL., Peng, X., SooHoo, C. K. & Tannenbaum, S. R. Protein adducts as biomarkers of human carcinogen exposure. Drug Metab. Rev. 26, 111-124 (1994).
50. Landi, M. T. et al. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels. Cancer Epidemiol. Biomarkers Prev. 5, 693-698 (1996).
51. Probst-Hensch, N. M. et al. N-Acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels. Cancer Epidemiol. Biomarkers Prev. 9, 619-623 (2000).
52. Castelao, J. E. et al. Gender and smoking-related bladder cancer risk. J. Natl Cancer Inst. 93, 538-545 (2001).
53. International Agency for Research on Cancer. Some industrial chemicals and dyestuffs. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans Vol. 29, 93-148 (IARC, Lyon, 1982).
54. Pryor, W. A., Stone, K., Zang, L. Y. & Bermudez, E. Fractionation of aqueous cigarette tar extracts: fractions that contain the tar radical cause DNA damage. Chem. Res. Toxicol. 11, 441-448 (1998).
55. Guengerich, F. P. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem. Res. Toxicol. 14, 611-650 (2001).
56. Cooper, C. S., Grover, P. L. & Sims, P. The metabolism and activation of benzo[a]pyrene. Prog. Drug Metab. 7, 295-396 (1983).
57. 7-(2-hydroxyethyl)guanine in rodents and its potential for human biological monitoring. Chem. Res. Toxicol. 12, 722-729 (1999).
58. Talaska, G. et al. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol. Biomarkers Prev. 1, 61-66 (1991).
59. Poirier, M. C. & Weston, A. in Encyclopedia of Cancer Vol. 2 (ed. Bernito, J. R.) 79-87 (Academic, London, 2002).
60. Wei, Q. et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J. Natl Cancer Inst. 92, 1764-1772 (2000).
61. Norbury, C. J. & Hickson, I. D. Cellular responses to DNA damage. Ann. Rev. Pharmacol. Toxicol. 41, 367-401 (2001).
62. Goode, E. L., Ulrich, C. M. & Potter, J. D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev. 11, 1513-1530 (2002).
63. 6-methylguanine specifically causes G to A mutations during cell replication.
64. Singer, B. & Essigmann, J. M. Site-specific mutagenesis: retrospective and prospective. Carcinogenesis 12, 949-955 (1991).
65. Seo, K. Y., Jelinsky, S. A. & Loechler, E. L. Factors that influence the mutagenic patterns of DNA adducts from chemical carcinogens. Mutat. Res. 463, 215-246 (2000).
66. Osada, H. & Takahashi, T. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene 21, 7421-7434 (2002).
67. Boysen, G., Kenney P. M. J., Upadhyaya, P., Wang, M. & Hecht, S. S. Effects of benzyl isothiocyanate and 2-phenethyl isothiocyanate on benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-butanone metabolism in F-344 rats. Carcinogenesis 24, 517-525 (2003).
68. Kensler, T. W., Groopman, J. D., Sutter, T. R., Curphey, T. J., & Roebuck, B. D. Development of cancer chemopreventive agents: Oltipraz as a paradigm. Chem. Res. Toxicol. 12, 113-126 (1999).
69. Adriaenssens, P. I., White, C. M. & Anderson, M. W. Dose-response relationships for the binding of benzo[a]pyrene metabolites to DNA and protein in lung, liver, and forestomach of control and butylated hydroxyanisole-treated mice, Cancer Res. 43, 3712-3719 (1983).
70. Miller, J. A. Research in chemical carcinogenesis with Elizabeth Miller - a trail of discovery with our associates. Drug Metabol. Dispos. 26, 1-36 (1994).
71. Schuller, H. M. Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nature Rev. Cancer 2, 455-463 (2002).
72. West, K. A. et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J. Clin. Invest. 111, 81-90 (2003).
73. Heeschen, C. et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nature Med. 7, 833-839 (2001).
74. Habs, M. & Schmahl, D. Influence of five different postnatal lifelong treatments on the transplacental carcinogenicity of ethylnitrosourea in Sprague-Dewley rats. Cancer Lett. 2, 93-100 (1976).
75. Gurkalo, V. K. & Volfson, N. I. Nicotine influence upon the development of experimental stomach tumors. Arch. Geschwulstforsch. 52, 259-265 (1982).
76. Bock, F. G. in Banbury Report 3: A Safe Cigarette? (eds Gori, G. B. & Bock, F. G.) 129-139 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1980).
77. Berger, M. R., Petru, E., Habs, M. & Schmahl, D. Influence of perinatal nicotine administration on transplacental carcinogenesis in Sprague-Dawley rats by N-methylnitrosourea. Br. J. Cancer 55, 37-40 (1987).
78. Chen, Y. P. & Squier, C. A. Effect of nicotine on 7,12-dimethylbenz[a]anthracene carcinogenesis in hamster cheek pouch. J. Natl Cancer Inst. 82, 861-864 (1990).
79. Chen, Y. P., Johnson, G. K. & Squier, C. A. Effects of nicotine and tobacco-specific nitrosamines on hamster cheek pouch and gastric mucosa. J. Oral Pathol. Med. 23, 251-255 (1994).
80. US Department of Health and Human Services. Survey of Compounds Which Have Been Tested for Carcinogenic Activity (GMA Industries, Inc., Annapolis, 2003).
81. Schuller, H. M., McGavin, M. D., Orloff, M., Riechert, A. & Porter, B. Simultaneous exposure to nicotine and hyperoxia causes tumors in hamsters. Lab. Invest. 73, 448-456 (1995).
82. Hecht, S. S., Carmella, S., Mori, H. & Hoffmann, D. Role of catechol as a major cocarcinogen in the weakly acidic fraction of smoke condensate. J. Natl Cancer Inst. 66, 163-169 (1981).
83. Van Duuren, B. L., Katz, C. & Goldschmidt, B. M. Brief communication: cocarcinogenic agents in tobacco carcinogenesis. J. Natl Cancer Inst. 51, 703-705 (1973).
84. Hoffmann, D. & Wynder, E. L. A study of tobacco carcinogenesis. XI. Tumor initiators, tumor accelerators, and tumor promoting activity of condensate fractions. Cancer 27, 848-864 (1971). Identifies the principal mouse-skin carcinogenic, cocarcinogenic and tumour-promoting fractions of cigarette-smoke condensate.
85. Dong, Z., Birrer, M. J., Watts, R. G., Matrisian, L. M. & Colburn, N. H. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl Acad. Sci. USA 91, 609-613 (1994).
86. Fischer, S. M. in Comprehensive Toxicology, Vol. 12, Chemical Carcinogens and Anticarcinogens (eds Bowden, G. T. & Fischer, S. M.) 349-381 (Elsevier Science, New York, 1997).
87. Baylin, S. B., Herman, J. G., Graft, J. R., Vertino, P. M. & Issa, J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72, 141-196 (1998).
88. Palmisano, W. A. et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 60, 5954-5958 (2000).
89. Hecht, S. S. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol. 3, 461-469 (2002).
90. Park, I. W. et al. Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer. J. Natl Cancer Inst. 91, 1863-1868 (1999).
91. Wistuba, I. I., Mao, L. & Gazdar, A. R. Smoking molecular damage in bronchial epithelium Oncogene 21, 7298-7306 (2002).
92. Harris, C. C. et al. Interindividual variation in binding of benzo[a]pyrene to DNA in cultured human bronchi. Science 194, 1067-1069 (1976). Shows large inter-individual differences in the ability to metabolically activate benzo[a] pyrene to DNA adducts.
93. World Health Organization World Cancer Report (eds Stewart, B. W. & Kleihues, P.) (IARC, Lyon, 2003).
94. Bach, P. B. et al. Variations in lung cancer risk among smokers. J. Natl Cancer Inst. 95, 470-478 (2003).
95. Kriek, E., Rojas, M., Alexandrov, K. & Bartsch, H. Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. Mutat. Res. 400, 215-231 (1998).
96. Wiencke, J. K. DNA adduct burden and tobacco carcinogenesis. Oncogene 21, 7376-7391 (2002).
97. Phillips, D. H. et al. Methods of DNA adduct determination and their application to testing compounds for genotoxicity. Environ. Mol. Mutagen. 35, 222-233 (2000).
98. Gammon, M. D. et al. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol. Biomarkers. Prev. 11, 677-685 (2002).
99. Veglia, F., Matullo, G. & Vineis, P. Bulky DNA adducts and risk of cancer: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 12, 157-160 (2003).
100. Tang, D. et al. Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Res. 61, 6708-6712 (2001).
101. Hecht, S. S. & Tricker, A. R. In Analytical Determination of Nicotine and Related Compounds and Their Metabolites (eds Gorrod, J. W. & Jacob, P.) 421-488 (Elsevier Science, Amsterdam, 1999).
102. Foiles, P. G. et al. Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. Chem. Res. Toxicol. 4, 364-368 (1991).
103. Tyroller, S., Zwickenpflug, W. & Richter, E. New sources of dietary myosmine uptake from cereals, fruits, vegetables, and milk. J. Agric. Food Chem. 50, 4909-4915 (2002).
104. Wilp, J., Zwickenpflug, W. & Richter, E. Nitrosation of dietary myosmine as risk factor of human cancer. Food Chem. Toxicol. 40, 1223-1228 (2002).
105. Osterman-Golkar, S., Ehrenberg, L., Segerback, D. & Hallstrom, I. Evaluation of genetic risks of alkyating agents II. Haemoglobin as a dose monitor. Mutat. Res. 34, 1-10 (1976).
106. Ehrenberg, L. & Osterman-Golkar, S. Alkylation of macromolecules for detecting mutagenic agents. Teratogenesis Carcinog. Mutagen. 1, 105-127 (1980).
107. Mowrer, J., Tornqvist, M., Jensen, S. & Ehrenberg, L. Modified Edman degradation applied to hemoglobin for monitoring occupational exposure to alkylating agents. Toxicol. Environ. Chem. 11, 215-231 (1986).
108. Tornqvist, M. & Ehrenberg, L. Estimation of cancer risk caused by environmental chemicals based on in vivo dose measurement. J. Environ. Pathol. Toxicol. Oncol. 20, 263-27 (2001).
109. Bergmark, E. Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers and nonsmokers. Chem. Toxicol. 10, 78-84 (1997).
110. Fennell, T. R. et al. Hemoglobin adducts from acrylonitrile and ethylene oxide in cigarette smokers: effects of glutathione-S-transferase T1-null and M1-null genotypes. Cancer Epidemiol. Biomarkers Prev. 9, 705-712 (2000).
111. Carmella, S. G. et al. Ethylation and methylation of hemoglobin in smokers and non-smokers. Carcinogenesis 23, 1903-1910 (2002).
112. Kopplin, A., Eberle-Adamkiewicz, G., Glusenkmo, K. H., Nehls, P. & Kirstein, U. Urinary excretion of 3-methyladenine and 3-ethyladenine after controlled exposure to tobacco smoke. Carcinogenesis 16, 2637-2641 (1995).
113. Prevost, V. & Shuker, D. E. G. Cigarette smoking and urinary 3-alkyladenine excretion in man. Chem. Res. Toxicol. 9, 439-444 (1996).
114. Godschalk, R. et al. Comparison of multiple DNA adduct types in tumor adjacent human lung tissue: effect of cigarette smoking. Carcinogenesis 23, 2081-2086 (2002).
115. Carmella, S. G., Akerkar, S. & Hecht, S. S. Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res. 53, 721-724 (1993).
116. Carmella, S. G., Akerkar, S., Richie, J. P. Jr & Hecht, S. S. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol. Biomarkers Prev. 4, 635-642 (1995).
117. Kresty L. A. et al. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship of urinary biomarkers and oral leukoplakia. Cancer Epidemiol. Biomarkers Prev. 5, 521-525 (1996).
118. Richie, J. P. et al. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol. Biomarkers Prev. 6, 783-790 (1997).
119. Hecht, S. S. et al. Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Cancer Epidemiol. Biomarkers Prev. 4, 877-884 (1995).
120. Taioli, E. et al. Effects of indole-3-carbinol on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers. Cancer Epidemiol. Biomarkers Prev. 6, 517-522 (1997).
121. Hecht, S. S. et al. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res. 59, 590-596 (1999).
122. Hecht, S. S. et al. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use. Cancer Res. 62, 129-134 (2002).
123. Hecht, S. S. et al. Effects of reduced cigarette smoking on uptake of a tobacco-specific lung carcinogen. J. Natl Cancer Inst. (in the press).
124. Hecht, S. S. et al. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N. Engl. J. Med. 329, 1543-1546 (1993).
125. Parsons, W. D., Carmella, S. G., Akerkar, S., Bonilla, L. E. & Hecht, S. S. A metabolite of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in the urine of hospital workers exposed to environmental tobacco smoke. Cancer Epidemiol. Biomarkers Prev. 7, 257-260 (1998).
126. Anderson, K. E. et al. Metabolites of a tobacco-specific lung carcinogen in the urine of nonsmoking women exposed to environmental tobacco smoke in their homes. J. Natl Cancer Inst. 93, 378-381 (2001). Establishes the presence of NNAL and NNAL-Glucs in the urine of non-smoking women exposed to environmental tobacco smoke at home, and relates the amounts of these to those in their smoking spouses.
127. Hecht, S. S. et al. Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children. Cancer Epidemiol. Biomarkers Prev. 10, 1109-1116 (2001).
128. Lackmann, G. M. et al. Metabolites of a tobacco-specific carcinogen in the urine of newborns. J. Natl Cancer Inst. 91, 459-465 (1999).
129. Milunsky, A., Carmella, S. G., Ye, M. & Hecht, S. S. A tobacco-specific carcinogen in the fetus. Prenat. Diagn. 20, 307-310 (2000).
130. 2-isoprostanes) in smokers. N. Engl. J. Med. 332, 1198-1203 (1995).
131. Nia, A. B. et al. Immunoperoxidase detection of polycyclic aromatic hydrocarbon-DNA adducts in mouth floor and buccal mucosa cells of smokers and nonsmokers. Environ. Mol. Mutagen. 36, 127-133 (2000).
132. 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers. Cancer Epidemiol. Biomarkers Prev. 9, 367-372 (2000).
133. Nia, A. B., Maas, L. M., Brouwer, E. M., Kleinjans, J. C. & van Schooten, F. J. Comparison between smoking-related DNA adduct analysis in induced sputum and peripheral blood lymphocytes. Carcinogenesis 21, 1335-1340 (2000).
134. Benhamou, S. et al. Meta- and pooled analyses of the effects of glutathione-S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 23, 1343-1350 (2002).
135. Caporaso, N. E. Why have we failed to find the low penetrance genetic constituents of common cancers? Cancer Epidemiol, Biomarkers Prev. 11, 1544-1549 (2002). Biomarkers Prev. 11, 1544-1549 (2002).
136. Bartsch, H. et al. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol. Biomarkers Prev. 9, 3-28 (2000).
137. Houlston, R. S. CYP1A1 polymorphisms and lung cancer risk: a meta-analysis. Pharmacogenetics 10, 105-114 (2000).
138. Spivack, S. D., Fasco, M. J., Walker, V. E. & Kaminsky, L. S. The molecular epidemiology of lung cancer. Crit. Rev. Toxicol. 27, 319-365 (1997).
139. Simpson, C. D. et al. Determination of r-7,t-8,9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene in human urine by gas chromatography-negative ion chemical ionization-mass spectrometry. Chem. Res. Toxicol. 13, 271-280 (2000).
140. Thun, M. J., Henley, S. J. & Calle, E. E. Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene 21, 7307-7325 (2002).
141. Skipper, R. L. & Stillwell, W. G. in Hemoglobins. Part B. Biochemical and Analytical Methods (eds Everse, J., Vandegriff, K. D. & Winslow, R. M.) 643-649 (Academic, San Diego, 1994).
142. Hecht, S. S., Carmella, S. G. & Murphy, S. E. Tobacco-specific nitrosamine hemoglobin adducts. Methods Enzymol. 231, 657-667 (1994).
143. Törnqvist, M. in Hemoglobins, Part B. Biochemical and Analytical Methods Vol. 231 (eds Everse, J., Vandegriff, K. D. & Winslow, R. M.) 650-657 (Academic, San Diego, 1994).
144. Hayes, R. B. et al. Mortality among benzene-exposed workers in China. Environ. Health Perspect. 104 (Suppl. 6), 1349-1352 (1996).
145. International Agency for Research on Cancer. Some industrial chemicals. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans Vol. 60, 73-159 (IARC, Lyon, 1994).